# | Title | Journal | Year | Citations |
---|
|
1 | Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus | Gut | 2013 | 5,102 |
2 | Global patterns and trends in colorectal cancer incidence and mortality | Gut | 2017 | 3,717 |
3 | The risk of colorectal cancer in ulcerative colitis: a meta-analysis | Gut | 2001 | 2,482 |
4 | Short chain fatty acids in human large intestine, portal, hepatic and venous blood. | Gut | 1987 | 2,451 |
5 | Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report | Gut | 2017 | 2,337 |
6 | Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability | Gut | 2009 | 2,123 |
7 | Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report | Gut | 2012 | 2,058 |
8 | Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification | Gut | 1999 | 2,002 |
9 | The Vienna classification of gastrointestinal epithelial neoplasia | Gut | 2000 | 1,868 |
10 | The gut microbiota and host health: a new clinical frontier | Gut | 2016 | 1,797 |
11 | Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut | 2014 | 1,529 |
12 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut | 2019 | 1,503 |
13 | Akkermansia muciniphilaand improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology | Gut | 2016 | 1,459 |
14 | A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitis | Gut | 2014 | 1,439 |
15 | Endoscopic mucosal resection for treatment of early gastric cancer | Gut | 2001 | 1,396 |
16 | Functional bowel disorders and functional abdominal pain | Gut | 1999 | 1,364 |
17 | The Oslo definitions for coeliac disease and related terms | Gut | 2013 | 1,350 |
18 | An increase in theAkkermansiaspp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice | Gut | 2014 | 1,344 |
19 | Kyoto global consensus report onHelicobacter pylorigastritis | Gut | 2015 | 1,342 |
20 | Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial | Gut | 2012 | 1,328 |
21 | Hepatocellular carcinoma: clinical frontiers and perspectives | Gut | 2014 | 1,200 |
22 | Prospective comparison of faecal incontinence grading systems | Gut | 1999 | 1,180 |
23 | Risk assessment after acute upper gastrointestinal haemorrhage. | Gut | 1996 | 1,172 |
24 | Guidelines for the management of inflammatory bowel disease in adults | Gut | 2011 | 1,156 |
25 | Global incidence of oesophageal cancer by histological subtype in 2012 | Gut | 2015 | 1,155 |
26 | British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus | Gut | 2014 | 1,149 |
27 | High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome | Gut | 2016 | 1,149 |
28 | Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. | Gut | 1980 | 1,148 |
29 | Butyrate inhibits inflammatory responses through NFkappa B inhibition: implications for Crohn's disease | Gut | 2000 | 1,089 |
30 | A simple clinical colitis activity index | Gut | 1998 | 1,087 |
31 | Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms | Gut | 2020 | 1,087 |
32 | Exercise and associated dietary extremes impact on gut microbial diversity | Gut | 2014 | 1,057 |
33 | Modern diagnosis of GERD: the Lyon Consensus | Gut | 2018 | 1,054 |
34 | Human gut microbiome: hopes, threats and promises | Gut | 2018 | 1,026 |
35 | Measurement of gastrointestinal pH profiles in normal ambulant human subjects. | Gut | 1988 | 1,021 |
36 | Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening | Gut | 2009 | 1,014 |
37 | Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults | Gut | 2015 | 1,010 |
38 | Fungal microbiota dysbiosis in IBD | Gut | 2017 | 993 |
39 | Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome | Gut | 2000 | 984 |
40 | European evidence-based guidelines on pancreatic cystic neoplasms | Gut | 2018 | 956 |
41 | Colorectal cancer screening: a global overview of existing programmes | Gut | 2015 | 951 |
42 | Proton pump inhibitors affect the gut microbiome | Gut | 2016 | 944 |
43 | A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increasedAkkermansiaspp. population in the gut microbiota of mice | Gut | 2015 | 938 |
44 | Short chain fatty acids in the human colon. | Gut | 1981 | 932 |
45 | Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer | Gut | 2017 | 926 |
46 | Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts | Gut | 2001 | 914 |
47 | Gut microbiome and health: mechanistic insights | Gut | 2022 | 914 |
48 | Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 | Gut | 2021 | 906 |
49 | Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives | Gut | 2011 | 905 |
50 | Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer | Gut | 2013 | 904 |